MTOR and cancer: In various cancer types, the mTOR complex is often over-activated due to the loss of tumor suppressors like phosphatase and tensin homologue (PTEN), activation of oncogenes such as phosphoinositide 3-kinase (PI3K) and metabolic reprogramming [45].